BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3349425)

  • 1. Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis.
    Bergman W; Ruiter DJ; Scheffer E; van Vloten WA
    Cancer; 1988 Apr; 61(8):1660-6. PubMed ID: 3349425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of histologic architectural and cytoplasmic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi.
    Barnhill RL; Roush GC; Duray PH
    Hum Pathol; 1990 Jan; 21(1):51-8. PubMed ID: 2295508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine structural and immunohistochemical properties of dysplastic melanocytic nevi: comparison with malignant melanoma.
    Jimbow K; Horikoshi T; Takahashi H; Akutsu Y; Maeda K
    J Invest Dermatol; 1989 May; 92(5 Suppl):304S-309S. PubMed ID: 2715663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi.
    Bergman W; Willemze R; de Graaff-Reitsma C; Ruiter DJ
    J Invest Dermatol; 1985 Jul; 85(1):25-9. PubMed ID: 3159801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of reflectance confocal microscopy in differentiating melanoma in situ from dysplastic nevi with severe atypia: A cross-sectional study.
    Fraga-Braghiroli N; Grant-Kels JM; Oliviero M; Rabinovitz H; Ferenczi K; Scope A
    J Am Acad Dermatol; 2020 Oct; 83(4):1035-1043. PubMed ID: 32442695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Focal melanocytic atypia in dysplastic nevus cell nevi. Results of a serial section study].
    Sigg C; Pelloni F; Schnyder UW
    Hautarzt; 1989 Nov; 40(11):701-7. PubMed ID: 2606669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigens associated with tumor progression in melanocytic neoplasia.
    Elder DE; Herlyn M
    Pigment Cell Res; 1992; Suppl 2():136-43. PubMed ID: 1409415
    [No Abstract]   [Full Text] [Related]  

  • 8. The dysplastic nevus: recognition and management.
    Barnhill RL; Hurwitz S; Duray PH; Arons MS
    Plast Reconstr Surg; 1988 Feb; 81(2):280-9. PubMed ID: 3275948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
    Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
    Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dysplastic nevus syndrome].
    Niebauer G; Kokoschka EM
    Wien Klin Wochenschr; 1986 Oct; 98(20):673-8. PubMed ID: 3788185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA determination in dysplastic nevi. A comparative study between flow cytometry and image analysis.
    Sangueza OP; Hyder DM; Bakke AC; White CR
    Am J Dermatopathol; 1993 Apr; 15(2):99-105. PubMed ID: 8494124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Architectural features in melanocytic lesions with cellular atypia.
    Balkau D; Gartmann H; Wischer W; Grootens A; Hagemeier HH; Hundeiker M; Suter L
    Dermatologica; 1988; 177(3):129-37. PubMed ID: 3169338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis.
    Strazzula L; Vedak P; Hoang MP; Sober A; Tsao H; Kroshinsky D
    J Am Acad Dermatol; 2014 Dec; 71(6):1071-6. PubMed ID: 25262175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nevomelanocytic atypia detection by in vivo reflectance confocal microscopy.
    Vaišnorienė I; Rotomskis R; Kulvietis V; Eidukevičius R; Zalgevičienė V; Laurinavičienė A; Venius J; Didžiapetrienė J
    Medicina (Kaunas); 2014; 50(4):209-15. PubMed ID: 25458957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hypothesis incorporating the histologic characteristics of dysplastic nevi into the normal biological development of melanocytic nevi.
    Piepkorn M
    Arch Dermatol; 1990 Apr; 126(4):514-8. PubMed ID: 2321996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the proteoglycans versican and mel-CSPG in dysplastic nevi.
    Touab M; Arumi-Uría M; Barranco C; Bassols A
    Am J Clin Pathol; 2003 Apr; 119(4):587-93. PubMed ID: 12710131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histological spectrum of acquired nevi. An analysis of the intraepidermal melanocytic proliferation in common and dysplastic nevi.
    Urso C; Bondi R
    Pathol Res Pract; 1994 Jun; 190(6):609-14. PubMed ID: 7984520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common acquired melanocytic nevi, dysplastic melanocytic nevi and malignant melanomas: an image analysis cytometric study.
    Bruijn JA; Berwick M; Mihm MC; Barnhill RL
    J Cutan Pathol; 1993 Apr; 20(2):121-5. PubMed ID: 8320355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology.
    Rhodes AR; Mihm MC; Weinstock MA
    Mod Pathol; 1989 Jul; 2(4):306-19. PubMed ID: 2762287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.